Group 1 - The core viewpoint of the news is that Changchun High-tech has seen a significant increase in its stock price, rising by 5.09% to 128.80 CNY per share, with a total market capitalization of 52.542 billion CNY [1] - Changchun High-tech was established on June 10, 1993, and listed on December 18, 1996. The company primarily engages in the research, production, and sales of biopharmaceuticals and traditional Chinese medicine, with a revenue composition of 92.83% from pharmaceuticals, 6.81% from real estate, and 0.36% from services [1] - The trading volume for Changchun High-tech reached 777 million CNY, with a turnover rate of 1.53% [1] Group 2 - According to data, one fund under CITIC Prudential has a significant holding in Changchun High-tech. The CITIC Prudential CSI 800 Pharmaceutical Index (LOF) A (165519) increased its holdings by 2,700 shares in the second quarter, bringing the total to 55,100 shares, which represents 2.18% of the fund's net value [2] - The CITIC Prudential CSI 800 Pharmaceutical Index (LOF) A (165519) was established on January 1, 2021, and has a current size of 235 million CNY. The fund has achieved a return of 28.93% this year, ranking 1892 out of 4220 in its category [2] - The fund manager, Huang Zhi, has been in charge for 7 years and 66 days, with the fund's total asset size at 3.01 billion CNY. The best return during his tenure was 146.63%, while the worst was -20.24% [3]
长春高新股价涨5.09%,中信保诚基金旗下1只基金重仓,持有5.51万股浮盈赚取34.37万元